Kidney cancer ablation study aims to confirm safety and success

NCT ID NCT07465458

First seen Mar 14, 2026 · Last updated May 19, 2026 · Updated 10 times

Summary

This study will observe 226 adults with early-stage kidney cancer (T1a) who are treated with radiofrequency ablation (RFA), a procedure that uses heat to destroy tumors. The goal is to gather more data on how well RFA works and its safety. No new treatments are being tested; all care is decided by the patient's own doctors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fondazione Poliambulanza Istituto Ospedaliero

    Brescia, Italy

    Contact

    Contact

  • Hospital Clínico Universitario

    Barcelona, Spain

    Contact

    Contact

  • Hospital Universitario Donostia

    San Sebastián, Spain

    Contact

    Contact

  • Hospital Universitario Fundación Jiménez Díaz

    Madrid, Spain

    Contact

    Contact

  • Hospital Universitario Puerta de Hierro

    Madrid, Spain

    Contact

    Contact

  • Hospital Universitario Reina Sofía

    Córdoba, Spain

    Contact

    Contact

  • Hospital Universitario de Leganés (Severo Ochoa)

    Madrid, Spain

    Contact

    Contact

  • IRCCS Ospedale San Raffaele

    Milan, Milano, Italy

  • Istituto Europeo di Onclologia ( IEO)

    Milan, Italy

    Contact Phone: •••-•••-••••

    Contact

  • Policlinico Universitario Campus Bio-Medico

    Roma, Italy

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.